STOCKHOLDERS’ EQUITY (Tables)

12 Months Ended

Dec. 31, 2023

Accumulated Other Comprehensive Income (Loss) [Line Items]

SCHEDULE OF STOCK WARRANTS VALUATION ASSUMPTIONS

The fair value of stock warrants granted for the year ended December 31, 2023 and 2022 was calculated with the following assumptions:

	2023			2022
Risk-free interest rate		4.29 – 4.95	%		1.37 – 4.45	%
Expected dividend yield		0	%		0	%
Volatility factor (monthly)		149.39	%		155.52	%
Expected life of warrant		5 years			5 years

SCHEDULE OF WARRANT ACTIVITY

The following table summarizes the Company’s Common Stock warrant activity for the year ended December 31, 2023 and 2022:

	Number of Warrants *			Weighted Average Exercise Price		Weighted Average Remaining Expected Term
Outstanding as at January 1, 2022		272,000		$	2.00		3.7
Granted		492,030			0.26		5.0
Exercised		(200,000	)		2.00		—
Forfeited/Cancelled		(22,000	)		2.00		—
Outstanding as at December 31, 2022		542,030		$	0.42		4.1
Granted		800,000			0.20		5.0
Exercised		—			—		—
Forfeited/Cancelled		—			—		—
Outstanding as at December 31, 2023		1,342,030		$	0.29		3.8

* The warrant agreements issued in 2019 for a total of 50,000 warrants include provisions for dilutive issuance and cash-less exercise. If exercised at December 31, 2023 the provisions would have resulted in an issuance of 1,130,114 shares at an average conversion price of $0.09, or 817,622 shares in a cash-less exercise. In order to mitigate the Company’s risk an administrative hold has been placed on one shareholder’s stock in the event of future exercise.

SCHEDULE OF WARRANT OUTSTANDING AND EXERCISABLE WARRANTS

The following table summarizes information about stock warrants that are vested or expected to vest at December 31, 2023 with a market price of $0.15 at December 31, 2023:

		Warrants Outstanding								Exercisable Warrants
Number of Warrants		Weighted Average Exercise Price Per Share		Weighted Average Remaining Contractual Life (Years)		Aggregate Intrinsic Value		Number of Warrants		Weighted Average Exercise Price Per Share		Weighted Average Remaining Contractual Life (Years)		Aggregate Intrinsic Value
	1,342,030	$	0.29		3.8	$	—		1,342,030	$	0.29		3.8	$	—

SCHEDULE OF NON-VESTED WARRANTS

The following table sets forth the status of the Company’s non-vested warrants as at December 31, 2023 and 2022.

	Number of Warrants		Weighted- Average Grant-Date Fair Value per share
Non-vested as at January 1, 2022		—	$	—
Granted		492,060		0.20
Forfeited/Cancelled		—		—
Vested		492,060		0.20
Non-vested as at December 31, 2022		—	$	—
Granted		800,000		0.20
Forfeited/Cancelled		—		—
Vested		800,000		0.20
Non-vested as at December 31, 2023		—	$	—

Common Stock [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

SCHEDULE OF STOCKHOLDER’S EQUITY

Issuances in the period January 1 and December 31, 2022 (restated)

Date		# Shares		Amount		Price/Share		Type	Notice
1/01/2022			110,840,998	$	5,992,717	$	0.054
7/07/2022	e		—		42,250		—	issuance of warrants
8/15/2022	a		1,400,000		598,000		0.430	private placement
8/15/2022	e		—		148,085		—	issuance of warrants
8/31/2022	b		6,081,484		1,520,371		0.250	convertible note
9/08/2022	c		4,139,503		—		—	exercise of warrants	cashless
11/28/2022	a		156,200		50,000		0.320	private placement
12/29/2022	a		93,750		30,000		0.320	private placement
see Note 10	d		280,000		78,240		0.279	2021 Stock Plan	affiliate
see Note 10	d		354,000		60,700		0.171	2021 Stock Plan
12/31/2022			123,345,985	$	8,520,455	$	0.069

Issuances in the period January 1 and December 31, 2023 (restated)

Date		# Shares		Amount		Price/Share		Type	Notice
1/01/2023			123,345,985	$	8,520,455	$	0.069
2/10/2023	a		156,250		50,000		0.320	private placement
4/14/2023	c		137,656		45,879		0.333	debt conversion
4/14/2023	c		6,763,562		2,254,197		0.333	debt conversion	affiliate
4/18/2023	a		78,125		25,000		0.320	private placement
5/10/2023	e		—		348,637		—	issuance of warrants
5/15/2023	a		114,286		40,000		0.350	private placement
5/17/2023	b		522,138		67,878		0.130	convertible note
6/26/2023	b		803,292		104,428		0.130	convertible note
7/26/2023	a		500,000		100,000		0.200	private placement
8/21/2023	f		1,612,903		145,161		0.090	public offering
8/21/2023	c		1,600,000		193,000		0.121	debt conversion
8/25/2023	a		505,186		68,200		0.135	private placement
8/30/2023	b		1,109,861		144,282		0.130	convertible note
9/14/2023	c		5,824,741		858,112		0.147	debt conversion	affiliate
9/19/2023	a		200,000		27,000		0.135	private placement
9/19/2023	a		370,370		50,000		0.135	private placement
see Note 10	d		463,163		106,348		0.230	2021 Stock Plan	affiliate
see Note 10	d		534,815		81,780		0.153	2021 Stock Plan
12/31/2023			144,642,333	$	13,229,387	$	0.091

a	The Company claims an exemption from the registration requirements of the Securities Act for the private placement of these securities pursuant to Section 4(a)(2) of the Securities Act and/or Rule 506 of Regulation D promulgated under the Securities Act.
b	The Common Stock underlying the Convertible Note(s) are currently eligible for resale under Rule 144. At the time of sale of the promissory note, the Company claimed an exemption from the registration requirements of the Securities Act for these securities pursuant to Section 4(a)(2) of the Securities Act and/or Rule 506 of Regulation D promulgated under the Securities Act.
c	The Company claims an exemption from the registration requirements of the Securities Act pursuant to the Exchange Exemption in Rule 3(a)(9) of the Securities Act.
d	The Company claims an exemption from the registration requirements of the Securities Act for the Compensatory Benefit Plan pursuant to Rule 701 of the Securities Act.
e	The Company claims an exemption from the registration requirements of the Securities Act pursuant to the Exchange Exemption in section 12(a) of the Securities Act.
f	The shares were issued after the Company filed a registration statement with the SEC, on Form S-1
g	The Company claims an exemption from the registration requirements of the Securities Act pursuant to the Exchange Exemption under Rule 145 of the Securities Act.
h	The Company claims an exemption from the registration requirements of the Securities Act pursuant to the Exchange Exemption under Rule 144 of the Securities Act.